Rheumatology

Latest News

Rheumatoid arthritis in hand | Image credit: yodiyim – stock.adobe.com
Subcutaneous Tocilizumab Superior to Methotrexate in Chinese Patients With RA

June 12th 2025

Tocilizumab alone and in combination with methotrexate outperformed the latter drug in patients who did not adequately respond to conventional synthetic disease-modifying antirheumatic drugs.

The connection between anemia and mortality among patients with RA could likely be explained by inflammation, explained the researchers. | Image credit: Matthieu - stock.adobe.com
Anemia Linked With Higher Risk of All-Cause, CVD-Related Mortality in Rheumatoid Arthritis

May 30th 2025

The authors wanted to better understand the problem of avoidable hospitalizations among people with rheumatoid arthritis. | Image credit: everythingpossible - stock.adobe.com
Rheumatoid Arthritis Linked With Heightened Risk of Avoidable Hospitalizations

May 8th 2025

Because serum analysis is already used to diagnose RA, track its progression, and understand response to therapy, the authors investigated whether reliable biomarkers could be found for refractory RA. | Image credit: angellodeco - stok.adobe.com
Serum Biomarkers for Refractory Active Rheumatoid Arthritis Remain Elusive

April 28th 2025

Using Telemedicine Interventions During COVID-19 to Expand Care Post COVID-19

January 24th 2023

More News

HRQoL in Plaque Psoriasis Improves With Biologics, Review Says
March 13th 2021

HRQoL in Plaque Psoriasis Improves With Biologics, Review Says

Larry Hanover
Five biologics used in the treatment of adult patients with plaque psoriasis have been found to improve health-related quality of life.
Is Using PASI 100 Realistic in a Real-Life Setting?
March 12th 2021

Is Using PASI 100 Realistic in a Real-Life Setting?

Larry Hanover
More real-world evidence is needed to determine what role a score of 100 on the Psoriasis Area and Severity Index (PASI) might have in daily clinical practice, according to a recent review.
Grandmother and granddaughter
March 5th 2021

Older Age Affects Initial Dosage of MTX Among Patients With RA

Larry Hanover
Elderly onset rheumatoid arthritis (RA) can be brought under control with a lower methotrexate (MTX) dosage than that required for young-onset disease.
Various ethnicities
March 4th 2021

Care Disparities Persist Among White, Minority Patients With Rheumatoid Arthritis

Larry Hanover
A recent study found that patients living in an an area with low socioeconomic status were less likely to be prescribed biological disease-modifying antirheumatic drugs if they were considered low-income and were male and African American.
Permanent Disability Claims for RA May Rise in Years Following COVID-19 Crisis
February 27th 2021

Permanent Disability Claims for RA May Rise in Years Following COVID-19 Crisis

Skylar Jeremias
From 1999 to 2015, permanent disability claims for patients with rheumatoid arthritis (RA) spiked during periods of economic recessions, suggesting that the COVID-19 pandemic may create a similar effect in the near future.
Skin affected by psoriasis
February 27th 2021

Using a Novel Inflammation Index to Predict Psoriasis Onset

Larry Hanover
The novel systemic-immune inflammation index (SII) can be used to predict the onset of psoriasis.
Study Compares Patients With RA and Those Without to Determine Multimorbidity Prevalence, Incidence
February 20th 2021

Study Compares Patients With RA and Those Without to Determine Multimorbidity Prevalence, Incidence

Allison Inserro
Multimorbidity affects 1 in 4 US adults and leads to increased health care use and lower quality of life.
Real-World Study Illustrates Secukinumab’s 24-Month Performance for Psoriatic Arthritis
February 20th 2021

Real-World Study Illustrates Secukinumab’s 24-Month Performance for Psoriatic Arthritis

Allison Inserro
The results from an analysis of patients from 12 rheumatology centers treated with secukinumab for psoriatic arthritis were in line with earlier pivotal trials, the researchers said.
IV infusion
February 11th 2021

Among Various Biologics, Abatacept Stands Out vs Conventional Treatment for RA

Jaime Rosenberg
Abatacept was shown to have a 9% increase in likelihood of achieving remission compared with conventional therapy for rheumatoid arthritis (RA), which the researchers contribute to the treatment’s lower discontinuation rates.
Researchers Report 2 Cases of Erythrodermic Psoriasis Effectively Treated With Secukinumab
February 8th 2021

Researchers Report 2 Cases of Erythrodermic Psoriasis Effectively Treated With Secukinumab

Gianna Melillo
After 4 weeks of a standard treatment regimen, patients demonstrated a 75% reduction in the Psoriasis Area and Severity Index score (PASI).
Rare, Severe Type of Psoriasis Merits Biologic Consideration, Researchers Say
February 6th 2021

Rare, Severe Type of Psoriasis Merits Biologic Consideration, Researchers Say

Allison Inserro
A recent study took a look at the use of biologics for generalized pustular psoriasis, a rare, potentially life-threatening inflammatory disorder.
Researchers Report First-Known Case of COVID-19–Triggered Psoriatic Arthritis
January 31st 2021

Researchers Report First-Known Case of COVID-19–Triggered Psoriatic Arthritis

Larry Hanover
An apparent first case of psoriatic arthritis triggered by coronavirus disease 2019 (COVID-19) was reported in a genetically predisposed patient.
TB testing analysis
January 28th 2021

Patient Safety, TB Risk Not Compromised by Secukinumab Use

Larry Hanover
Secukinumab rarely leads to latent tuberculosis infection as a reported adverse event and is supported for use in treating chronic systemic inflammatory conditions.
ACR Sets 2021 Policy Priorities for Congress, Biden Administration
January 27th 2021

ACR Sets 2021 Policy Priorities for Congress, Biden Administration

Skylar Jeremias
The American College of Rheumatology (ACR) announced a number of policy priorities that it is encouraging the new Congress and administration to focus on during the year.
Scaly, irritated skin
January 25th 2021

Researchers Try to Replicate Secukinumab, Ustekinumab Study With Registry Data

Allison Inserro
The study sought to understand how psoriasis treatments perform in real-world settings.
someone working on a laptop with charts and data surrounding it
January 15th 2021

CMS Finalizes Rule on Electronic Prior Authorization

Skylar Jeremias
CMS finalized a rule on electronic data entry that will streamline the prior authorization process and improve data transparency for providers, payers, and patients.
Study Identifies Potential New Biomarkers of ILD in Rheumatoid Arthritis
January 6th 2021

Study Identifies Potential New Biomarkers of ILD in Rheumatoid Arthritis

Gianna Melillo
Study findings, published in Frontiers in Medicine, underscore the importance of metabolic profiling for discovering candidate screening biomarkers for interstitial lung disease (ILD) in rheumatoid arthritis.
Man holding his hand
December 31st 2020

Psoriatic Arthritis, Rheumatoid Arthritis Cause Similar Hand Impairment, but So Does Psoriasis

Jared Kaltwasser
In an unexpected finding, patients with psoriasis showed similar hand impairment to patients with psoriatic arthritis and rheumatoid arthritis.
Depression Prevalence Found to Be Higher in PsA Than RA, Diabetes
December 29th 2020

Depression Prevalence Found to Be Higher in PsA Than RA, Diabetes

Skylar Jeremias
A Greek study examined the prevalence of comorbidities in patients with rheumatoid arthritis (RA), diabetes, and psoriatic arthritis (PsA).
Secukinumab Improves Signs, Symptoms of Axial Disease in Patients With PsA
December 24th 2020

Secukinumab Improves Signs, Symptoms of Axial Disease in Patients With PsA

Jaime Rosenberg
Both secukinumab 300 mg and secukinumab 150 mg significantly improved signs and symptoms of axial disease in patients with psoriatic arthritis (PsA) who had inadequate response to non- steroidal anti-inflammatory drugs.
Study Examines Activity Levels in Patients With Psoriatic Arthritis
December 12th 2020

Study Examines Activity Levels in Patients With Psoriatic Arthritis

Jaime Rosenberg
The study showed that that patients with higher disease activity had significantly lower levels of physical activity.
Site Logo
December 12th 2020

Rheumatoid Arthritis Medication Adherence in a Health System Specialty Pharmacy

Nate Berger, PharmD, MBA Megan Peter, PhD Josh DeClercq, MS Leena Choi, PhD Autumn D. Zuckerman, PharmD
Integrated health system specialty pharmacies provide specialized services to patients, resulting in high rates of adherence to and financial assistance with specialty disease-modifying antirheumatic drugs.
psoriatic arthritis hand
December 5th 2020

Secukinumab Has a Greater Persistence Rate Than Ustekinumab in Psoriatic Arthritis

Laura Joszt, MA
In the real world, the persistence rate with secukinumab to treat psoriatic arthritis was higher than with ustekinumab.
Algorithm Pipeline Aids in Identification of Patients With RA
December 3rd 2020

Algorithm Pipeline Aids in Identification of Patients With RA

Gianna Melillo
Using machine learning methods researchers were able to extract records of patients with rheumatoid arthritis (RA) from electronic health record data with high precision, enabling research on very large populations with this condition for limited costs.
Arthritis hand pain
November 19th 2020

Guideline Updates for RA, JIA Recommend Maximizing Biologics and Reducing Steroid Use

Laura Joszt, MA
At its annual meeting, the American College of Rheumatology previewed updates to guidelines for the management of rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA).
US Rheumatologists Reluctant to Switch to Biosimilars for Patients Doing Well on a Reference Product
November 16th 2020

US Rheumatologists Reluctant to Switch to Biosimilars for Patients Doing Well on a Reference Product

Laura Joszt, MA
Although half of US rheumatologists have patients for which nonmedical switching has been suggested, only 35% were likely to switch patients with rheumatoid arthritis doing well on a reference product to a biosimilar.
stethoscope on a laptop
November 11th 2020

Telemedicine Improved Appointment Adherence for Rheumatology Visits

Laura Joszt, MA
Improvements in completed visits while using telemedicine to conduct rheumatology visits during the coronavirus disease 2019 pandemic may present an option for continued telemedicine use for follow-up care.
Black and White hands holding up the world
November 9th 2020

Black Patients With RA Less Likely Than White Counterparts to Be Prescribed a Biologic

Jaime Rosenberg
The study also found that Black patients with rheumatoid arthritis (RA) are more likely to be prescribed glucocorticoids, which come with a risk of serious long-term adverse effects.
Caduceus
November 5th 2020

Data Show Novartis’ Secukinumab Leads to Early Synovitis Reduction in Patients With PsA

Gianna Melillo
New results from the phase 3 ULTIMATE trial show Novartis’ Cosentyx (secukinumab) demonstrated significant treatment response on synovitis in patients with active psoriatic arthritis (PsA) compared with placebo.
doctor and patient
November 4th 2020

Patients With Rheumatic Diseases at No Greater Risk of Contracting COVID-19

Laura Joszt, MA
Despite concerns about treatment with immunosuppressive agents, coronavirus disease 2019 (COVID-19) infection remains low in patients with rheumatic diseases, according to 2 abstracts presented at the annual meeting of the American College of Rheumatology.
<1234567891011>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo